In a groundbreaking move, Wellesta Holdings and Ancom Truelife have come together in a pioneering partnership aimed at revolutionizing breast cancer detection in Malaysia. The collaboration centers on the integration of advanced AI technology into healthcare, with the goal of significantly improving the early detection of breast cancer and, ultimately, the lives of countless Malaysian women.

"We are thrilled to share fantastic news from our dedicated distributor, Wellesta. This remarkable partnership signifies an important step towards enhancing early breast cancer detection and, ultimately, improving the health and lives of Malaysian women," said Dr. Amanda Chen, CEO of Ancom Truelife.

Wellesta Holdings, led by Milan Paleja, Chairman, and Managing Director, has embraced the power of FxMammo, an AI-based software developed by @FathomX. This innovative software promises to assist radiologists in making quicker and more accurate decisions when diagnosing breast cancer, a disease that continues to be a leading cause of cancer-related deaths among women.

With Malaysia's screening rate standing at a mere 3.6%, and a shortage of radiologists, FxMammo's remarkable capability to rapidly and accurately analyze mammograms in just two to three minutes will have a profound impact on cancer detection. The software has recently received approval from the Malaysian Device Authority (MDA), paving the way for its implementation in both private and government healthcare institutions equipped with mammogram machines.

This initiative aligns seamlessly with the Malaysian government's vision of promoting a healthier nation, and with this partnership, Wellesta and Ancom Truelife are committed to creating a healthcare system that is not only more accessible but also highly efficient in the fight against breast cancer.

Breast cancer knows no boundaries, and this collaborative effort is a significant leap forward in ensuring that women across Malaysia receive the best possible care and treatment when it comes to their breast health. It's a momentous stride towards a healthier, brighter future for all